Related references
Note: Only part of the references are listed.Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy
A. Harrer et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression
Pedro Lourenco et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Jack Antel et al.
ACTA NEUROPATHOLOGICA (2012)
Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis
Luisa M. Villar et al.
ARCHIVES OF NEUROLOGY (2012)
Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions
Maria C. Sadaba et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
Markus C. Kowarik et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual
Laurence Durante et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
Ayumi Yoshizaki et al.
NATURE (2012)
Progressive multiple sclerosis: pathology and pathogenesis
Hans Lassmann et al.
NATURE REVIEWS NEUROLOGY (2012)
Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes
Maria Jose Magraner et al.
NEURORADIOLOGY (2012)
Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM
Patrizia Sola et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
Laura Piccio et al.
ARCHIVES OF NEUROLOGY (2010)
Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis
Luisa M. Villar et al.
CLINICAL IMMUNOLOGY (2010)
Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial
Kathleen Hawker et al.
ANNALS OF NEUROLOGY (2009)
Primary-progressive multiple sclerosis (vol 6, pg 903, 2007)
D. Miller et al.
LANCET NEUROLOGY (2009)
A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses
Koichi Yanaba et al.
IMMUNITY (2008)
Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis
M. Thangarajh et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Primary-progressive multiple sclerosis
David H. Miller et al.
LANCET NEUROLOGY (2007)
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial
Jerry S. Wolinsky et al.
ANNALS OF NEUROLOGY (2007)
Cerebrospinal fluid IgM index correlates with cranial MRI lesion load in patients with multiple sclerosis
Peter J. H. Jongen et al.
EUROPEAN NEUROLOGY (2007)
Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct
Kerstin Imrell et al.
NEUROLOGY (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Multiple sclerosis severity score -: Using disability and disease duration to rate disease severity
RHSR Roxburgh et al.
NEUROLOGY (2005)
Early differential diagnosis of multiple sclerosis using a new oligoclonal band test
LM Villar et al.
ARCHIVES OF NEUROLOGY (2005)
An ultrasensitive method for the detection of oligoclonal IgG bands
MC Sadaba et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis
LM Villar et al.
ANNALS OF NEUROLOGY (2003)
Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS
LM Villar et al.
NEUROLOGY (2002)
Intrathecal IgM synthesis in neurologic diseases:: Relationship with disability in MS
LM Villar et al.
NEUROLOGY (2002)
CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity
KM Ansel et al.
IMMUNITY (2002)
A sensitive and reproducible method for the detection of oligoclonal IgM bands
LM Villar et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Share Paper
